IMARC Group, a leading market research company, has recently releases report titled “Intravenous (IV) Therapy and Vein Access Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033,” The study provides a detailed analysis of the industry, including the global intravenous (IV) therapy and vein access market size, share, trends, and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the intravenous (IV) therapy and vein access market?
The global intravenous (IV) therapy and vein access market size reached USD 26.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.4% during 2025-2033.
Factors Affecting the Growth of the Intravenous (IV) Therapy and Vein Access Industry:
- Increasing Prevalence of Chronic Diseases:
The escalating prevalence of chronic diseases, including cancer, diabetes, and cardiovascular ailments, is a primary factor driving the market growth. Chronic diseases often necessitate long-term management, which frequently involves the administration of medications and fluids via intravenous (IV) routes. Furthermore, patients undergoing chemotherapy for cancer, insulin therapy for diabetes, or cardiovascular treatments rely on IV therapy for efficient drug delivery and management of their conditions. This has led to the heightened demand for reliable vein access devices such as catheters, infusion pumps, and needles. Moreover, the rising incidence of chronic diseases due to factors such as sedentary lifestyles and unhealthy dietary habits, leading to the increasing need for effective IV therapy solutions, is favoring the market growth.
- Rising Geriatric Population:
The elevating geriatric population across the globe represents a significant factor driving the market growth. Advancing age comes with a higher prevalence of age-related health conditions, such as hypertension, arthritis, and cardiovascular diseases, which often require medical interventions involving IV therapy. Furthermore, geriatric individuals frequently undergo surgeries, treatments, and hospitalizations, during which reliable vein access becomes crucial for delivering medications, fluids, and nutrients effectively. Moreover, age-related physiological changes, such as decreased vein elasticity and integrity, which can pose challenges in venous access, necessitating the use of specialized devices and techniques, are driving the market growth.
- Technological Advancements:
Continuous research and development (R&D) efforts, which have led to the introduction of advanced vein access devices equipped with features such as smart infusion pumps, integrated monitoring systems, and improved catheter materials, are boosting the market growth. These technological innovations aim to enhance the safety, efficacy, and convenience of IV therapy procedures for both patients and healthcare providers. Furthermore, the integration of wireless connectivity and digital interfaces in infusion pumps, which enables remote monitoring of infusion parameters, infusion rate adjustments, and early detection of potential complications, thereby improving patient outcomes and reducing healthcare costs, is positively impacting the market growth. Along with this, the development of catheter materials with enhanced biocompatibility and thromboresistance, which reduces the risk of catheter-related complications such as infections and thrombosis, is driving the market growth.
Request for a sample copy of this report: https://www.imarcgroup.com/intravenous-therapy-vein-access-market/requestsample
Intravenous (IV) Therapy and Vein Access Market Report Segmentation:
Breakup By Type:
- Implantable Ports
- Intravenous Catheters
- Hypodermic Needles
- Infusion Pumps
- Others
Intravenous catheters hold the majority of the market share due to their widespread use in various medical procedures and treatments, including surgery, chemotherapy, and critical care, necessitating reliable vein access for medication delivery and fluid administration.
Breakup By Application:
- Nutrition and Buffer Solution
- Volume Expander
- Medication Administration
- Blood Based Products
Medication administration accounted for the largest market share as it encompasses a broad spectrum of healthcare settings and patient populations, including hospitals, clinics, and home healthcare, where intravenous therapy is routinely utilized for administering medications such as antibiotics, pain relievers, and chemotherapy drugs.
Breakup By End User:
- Hospitals
- Ambulatory Surgical Center
- Clinics
Hospitals represented the largest segment, owing to their role as primary healthcare providers, where a significant volume of IV therapy procedures are conducted for patients undergoing surgeries, treatments, and medical interventions, necessitating reliable vein access devices and expertise in intravenous administration.
Breakup By Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America’s dominance in the market is attributed to factors such as high healthcare spending, advanced healthcare infrastructure, and a large patient population requiring intravenous therapy, driving the demand for vein access devices.
Global Intravenous (IV) Therapy and Vein Access Market Trends:
The growing number of surgical procedures, both elective and emergency, which require reliable and efficient vein access, is boosting the market growth. Besides this, the increasing hospital admissions due to various ailments, surgeries, and treatments necessitating extensive IV therapy is stimulating the market growth. Additionally, the shifting trend towards home-based healthcare services for chronic diseases and post-operative care, prompting the adoption of portable and easy-to-use IV therapy devices, is strengthening the market growth. Furthermore, the heightened awareness regarding the prevention and control of infectious diseases, especially in healthcare settings, is acting as another growth-inducing factor.
Top Intravenous (IV) Therapy and Vein Access Market Leaders:
The intravenous (IV) therapy and vein access market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies.
Some of the key players in the market are:
- AngioDynamics Inc.
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton Dickinson and Company
- Cardinal Health Inc.
- Fresenius SE & Co. KGaA
- ICU Medical Inc.
- Medtronic plc
- Tekni-Plex Inc.
- Teleflex Incorporated
- Terumo Corporation
- Vygon SAS
Ask Analyst Browse full report with TOC List of Figures: https://www.imarcgroup.com/request?type=report&id=7524&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.
IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
